Status:
COMPLETED
Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Antibiotic Reaction
Bone and Joint Infection
Eligibility:
All Genders
18-100 years
Brief Summary
Cephamycin related to 2nd generation cephalosporins, the use of cefoxitin has long been limited to antibiotic prophylaxis. Because of its spectrum (sensitive staphylococci, enterobacteria including ES...
Eligibility Criteria
Inclusion
- patients havind had a bon and joint infeciton treated with cefoxitin in combination in continuous parenteral administration
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03848104
Start Date
January 1 2018
End Date
April 1 2018
Last Update
February 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004